Indivior Pharmaceuticals, Inc.

INDV · Healthcare

$34.56

Markedsværdi: 4.08B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Indivior Pharmaceuticals, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Zacks Investment Research2. sep. 2026, 15.30

Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound?

Indivior Pharmaceuticals beat Q2 2026 earnings estimates with adjusted EPS of $1.15 (vs. $0.97 consensus) and revenues of $343 million (vs. $308 million consensus), driven by strong Sublocade performance. The company raised its full-year 2026 guidance and improved profitability through cost management. Despite these positive results, shares have declined 5.3% since the earnings report, underperforming the S&P 500. The stock holds a Zacks Rank #2 (Buy) with upward estimate revisions.